Medical Doctor Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Jose Perez

Sports Medicine Hialeah, FL Medical Doctor

NPI 1902301377 CMS profile 11555718

7100 W 20Th Ave Ste 101, Hialeah, FL 33016

Open in the dashboard

General payments

$37,700

109 records reported · program years 2023–2025

Research payments

$600

Paid to them · 1 record reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jose Perez of Hialeah, FL is reported in the CMS Open Payments database as having received $37,700 across 109 general payments and $600 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 81st percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $11,399 36
2025 Research $600 1
2024 General $4,190 48
2023 General $22,112 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jose Perez
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Jose Perez were reported at $11,399. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Jose Perez Sports Medicine median Middle half National median
2019 $0 $1,176 $199–$4,249 $163
2020 $0 $708 $96–$2,890 $114
2021 $0 $1,213 $152–$3,994 $132
2022 $0 $1,230 $159–$3,998 $149
2023 $22,112 $584 $146–$2,836 $160
2024 $4,190 $628 $163–$3,168 $164
2025 $11,399 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. Arthrex, Inc. $24,750 33 payments
  2. Nalu Medical, Inc. $6,435 12 payments
  3. Stryker Corporation $3,133 40 payments
  4. aap Implants Inc $1,000 1 payment
  5. Southern Edge Orthopaedics, Inc. $723 4 payments
  6. Suvon Surgical LLC $685 7 payments
  7. Smith+Nephew, Inc. $469 5 payments
  8. Zimmer Biomet Holdings, Inc. $226 4 payments
  9. DePuy Synthes Sales Inc. $139 1 payment
  10. Arcuro Medical Inc $113 1 payment
  11. Other $26 1 payment

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Grant $20,000 1 payment
  2. Travel and Lodging $7,303 18 payments
  3. Food and Beverage $5,121 86 payments
  4. Consulting Fee $2,750 1 payment
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,500 2 payments
  6. Entertainment $26 1 payment
Products named General payments · program years 2023–2025
  1. Nalu Neurostimulation System $6,435 12 payments
  2. ICONIX $1,028 2 payments
  3. GAMMA $406 7 payments
  4. T2 ALPHA $304 7 payments
  5. T2 $238 3 payments
  6. REAL INTELLIGENCE $188 2 payments
  7. TRIATHLON $185 3 payments
  8. PANGEA $173 3 payments
  9. TANDEM $150 1 payment
  10. LEGION Revision $150 1 payment
  11. Other $1,793 25 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2023–2025
  1. aap Implants Inc $600 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

81

Median for Orthopedic Surgery: 203

Drug cost

$279

Median for Orthopedic Surgery: $1,433

Branded share of claims

14.8%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 12 $114
Meloxicam Generic 54 $83
Ibuprofen Generic 15 $83

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 26 billing codes

Paid by Medicare

$16,732

Medicare's payments for the services billed

Medicare patients

31

Average age 78

Services billed

106

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 65%
Diabetes 55%
Ischemic heart disease 55%
Depression 55%
COPD 35%
Alzheimer's or dementia 35%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

110 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record